Skip to main content

Missouri Judge Upholds $4.7 Billion Talcum Verdict

Missouri Judge Upholds $4.7 Billion Talcum Verdict

Missouri Judge Upholds $4.7 Billion Talcum Verdict

Introduction

Judge Rex Burlison in Missouri’s 22nd Circuit Court, St. Louis, confirmed on Tuesday the $4.7 billion award for 22 plaintiffs who alleged that asbestos presence in Johnson & Johnson's talcum products causes ovarian cancer.

Even as the talcum giant strongly denies its products contain carcinogenic asbestos, the case concluded in July in Missouri, as the jury found documents affirming that the company was aware of the risks of talcum and falsely marketed the product.

As per jury's verdict, $550 million has been awarded to the plaintiffs as compensatory damages, and an additional $4.14 billion in punitive damages. Each plaintiff along with the families of 6 women who died of ovarian cancer has been awarded $25 million. The verdict was one of the largest involving Johnson & Johnson talcum powder litigation, which holds more than 10,000 claims. J&J vows to appeal Missouri court’s judgment soon. The talcum manufacturer also faces several claims regarding asbestos exposure causing mesothelioma, which is a rare form of cancer affecting the heart, lungs, and abdomen.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!